- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TAK
Recent news which mentions TAK
Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy
November 10, 2023
Tickers
TAK
From Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Looking Into Takeda Pharmaceutical's Recent Short Interest
November 03, 2023
Tickers
TAK
From Benzinga
Earnings Scheduled For October 26, 2023
October 26, 2023
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 19, 2023
Tickers
TAK
From Benzinga
Takeda's Crohn's Disease Fistulas Candidates Fall Short In Mid-Stage Study, Settles Tax Dispute With Irish Revenue Commissioners
October 18, 2023
From Benzinga
Looking Into Takeda Pharmaceutical's Recent Short Interest
October 11, 2023
Tickers
TAK
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 04, 2023
Tickers
TAK
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
From Benzinga
Can Japan's Economy Continue To Blossom If Bank of Japan Raises Rates? Apparently So.
October 02, 2023
From Benzinga
Morphic Therapeutic's Stock Plunges On Monday - Here's Why?
September 25, 2023
From Benzinga
Looking Into Takeda Pharmaceutical's Recent Short Interest
September 25, 2023
Tickers
TAK
From Benzinga
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
From Benzinga
From Benzinga
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
September 08, 2023
Tickers
TAK
From Benzinga
From Benzinga
From Motley Fool
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now
August 23, 2023
From Motley Fool
Why Are Poseida Therapeutics Shares Moving Higher Today?
August 07, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
From Benzinga
3 AI Stocks That Could Skyrocket Your Wealth
June 20, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.